Recent News

• 05.18.2026 - PIPE-791 and BMS-986278: Two Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists with Distinct Lung Occupancy Profiles and Vascular Effects
• 05.18.2026 - LPA1 Antagonism by PIPE-791 Reduces Alveolar Epithelial Cell Apoptosis In Vitro

Recent Filings

• 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.05.2026 - EX-99.1 EX-99.1
• 05.05.2026 - 8-K Current report
• 05.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.01.2026 - 144 Report of proposed sale of securities
• 05.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.30.2026 - DEF 14A Other definitive proxy statements
• 04.30.2026 - 8-K Current report
• 04.30.2026 - EX-99.1 EX-99.1